Skip to main content
Clinical Trials/NCT01935752
NCT01935752
Completed
Not Applicable

Pathophysiological Mechanisms of Fibromuscular Dysplasia

Assistance Publique - Hôpitaux de Paris1 site in 1 country150 target enrollmentNovember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromuscular Dysplasia
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
150
Locations
1
Primary Endpoint
Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Fibromuscular dysplasia is an non inflammatory non atherosclerotic obstructive arterial disease affecting mid-size arteries. It is considered as a rare vascular disease of unknown origin. Fibromuscular dysplasia may become symptomatic depending on location and severity of narrowing of the arterial lumen. for example,when a stenosis develops within a renal artery, arterial hypertension may develop. The cause of fibromuscular dysplasia is unknown. Several factors have been suggested to be associated with it: tobacco abuse or oestrogens. In order to progress into identifying possible causative mechanisms of the disease, we design a pathophysiology study destined to assess endothelial function in patients with fibromuscular dysplasia and to identify possible plasmatic biomarkers of the disease.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
October 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Comparison of circulating microparticles of patients vs. fibromuscular dysplasia with age and sex matched healthy volunteers and hypertensive patients

Time Frame: Once within 15 days

Secondary Outcomes

  • Comparison of circulating micro RNAs (miR-143 ; miR-145) between the 3 arms(Once within 15 days)
  • Comparison of c-reactive protein between the 3 arms(Once within 15 days)
  • Comparison of pulse wave velocity between the 3 arms(Once within 15 days)
  • Comparison of endothelium dependant vasodilation between the 3 arms(Once within 15 days)
  • Comparison of endothelium independent vasodilation between the 3 arms(Once within 15 days)
  • Comparison of matrixmetalloproteases between the 3 arms(Once within 15 days)
  • Comparison of PLA2 between the 3 arms(Once within 15 days)

Study Sites (1)

Loading locations...

Similar Trials